Who owns CENTESSA PHARMACEUTICALS PLC?
- Ticker: CNTA
- CUSIP Number: 152309100
Tip: Access positions for across all investors
Analyze quarterly positions in Centessa Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Centessa Pharmaceuticals stock
Who bought or sold CENTESSA PHARMACEUTICALS PLC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Medicxi Ventures Management | 20M | $226M | 0% | Mar 2024 |
|
| General Atlantic | 9.7M | $109M | 0% | Mar 2024 |
|
| EcoR1 Capital | 5.6M | $64M | 0% | Mar 2024 |
|
| Vida Ventures Advisors | 3.9M | $44M | 0% | Mar 2024 |
|
| Perceptive Advisors | 3.1M | $35M | 100% | Mar 2024 |
|
| First Light Asset Management | 3.0M | $34M | 100% | Mar 2024 |
|
| T. Rowe Price Associates | 3.0M | $33M | 16% | Mar 2024 |
|
| FMR | 2.8M | $32M | 0% | Mar 2024 |
|
| Point72 Asset Management | 2.3M | $26M | 23% | Mar 2024 |
|
| Adage Capital Partners GP | 2.3M | $25M | -21% | Mar 2024 |
|
| Morgan Stanley | 2.1M | $26M | 123% | Mar 2024 |
|
| Octagon Capital Advisors | 2.1M | $23M | 0% | Mar 2024 |
|
| Artal Group | 1.4M | $16M | 40% | Mar 2024 |
|
| 5AM Venture Management | 1.2M | $14M | 100% | Mar 2024 |
|
| Franklin Resources | 1.2M | $13M | 4% | Mar 2024 |
|
| American Century Companies | 923k | $10M | 33% | Mar 2024 |
|
| Tanager Wealth Management | 696k | $7.9M | 0% | Mar 2024 |
|
| Cormorant Asset Management | 562k | $6.3M | 0% | Mar 2024 |
|
| Platinum Investment Mangement | 485k | $5.5M | 44% | Mar 2024 |
|
| BlackRock | 383k | $4.3M | 17% | Mar 2024 |
|
| ExodusPoint Capital Management | 379k | $4.3M | 100% | Mar 2024 |
|
| Farallon Capital Management | 371k | $4.2M | 100% | Mar 2024 |
|
| Millennium Management | 287k | $3.2M | 576% | Mar 2024 |
|
| Exome Asset Management | 275k | $3.1M | 100% | Mar 2024 |
|
| Balyasny Asset Management | 254k | $2.9M | 100% | Mar 2024 |
|
| Marshall Wace | 232k | $2.6M | 100% | Mar 2024 |
|
| TD Asset Management | 229k | $2.6M | 23% | Mar 2024 |
|
| ADAR1 Capital Management | 207k | $2.3M | 100% | Mar 2024 |
|
| Ensign Peak Advisors | 125k | $1.4M | 0% | Mar 2024 |
|
| Landscape Capital Management | 90k | $1.0M | 100% | Mar 2024 |
|
| Two Sigma Investments | 79k | $890k | 377% | Mar 2024 |
|
| Bank of America Corporation | 77k | $870k | 108% | Mar 2024 |
|
| Cubist Systematic Strategies | 73k | $821k | 1405% | Mar 2024 |
|
| Citadel Advisors | 70k | $787k | -39% | Mar 2024 |
|
| Springbok Capital Management | 69k | $781k | 100% | Mar 2024 |
|
| Goldman Sachs Group | 55k | $622k | 123% | Mar 2024 |
|
| Geode Capital Management | 34k | $379k | 5% | Mar 2024 |
|
| Rathbones Brothers | 31k | $354k | 0% | Mar 2024 |
|
| Acadian Asset Management | 29k | $330k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 27k | $308k | 156% | Mar 2024 |
|
| Lynx1 Capital Management | 17k | $197k | 100% | Mar 2024 |
|
| Trexquant Investment | 14k | $114k | 100% | Dec 2023 |
|
| Jump Financial | 14k | $114k | 100% | Dec 2023 |
|
| GSA Capital Partners | 14k | $154k | 100% | Mar 2024 |
|
| China Universal Asset Management | 11k | $122k | 69% | Mar 2024 |
|
| Qube Research & Technologies | 8.9k | $101k | 12862% | Mar 2024 |
|
| Quarry | 6.5k | $74k | 8% | Mar 2024 |
|
| State of Tennessee, Treasury Department | 5.8k | $66k | 100% | Mar 2024 |
|
| Zurcher Kantonalbank | 2.3k | $26k | 100% | Mar 2024 |
|
| UBS Group | 1.9k | $21k | 19% | Mar 2024 |
|
| Advisors Preferred | 1.8k | $20k | 100% | Mar 2024 |
|
| GAMMA Investing | 1.5k | $17k | 164% | Mar 2024 |
|
| Tower Research Capital | 1.0k | $11k | -67% | Mar 2024 |
|
| Adirondack Trust | 925.00 | $11k | 0% | Mar 2024 |
|
| Global Retirement Partners | 700.00 | $7.9k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 616.00 | $0 | 577% | Mar 2024 |
|
| Advisor Group Holdings | 300.00 | $3.4k | -85% | Mar 2024 |
|
| Daiwa Securities Group | 211.00 | $2.0k | 0% | Mar 2024 |
|
| Citigroup | 204.00 | $2.3k | -80% | Mar 2024 |
|
| Nbc Securities | 138.00 | $1.0k | 0% | Mar 2024 |
|
| Caldwell Sutter Capital | 86.00 | $971.997800 | -50% | Mar 2024 |
|
| Spire Wealth Management | 70.00 | $791.000000 | 0% | Mar 2024 |
|
| Compagnie Lombard, Odier SCA | 0 | $0 | -100% | Mar 2024 |
|
Who sold out of Centessa Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BVF | Dec 2023 | 8.8M | $70M |
| Sio Capital Management | Sep 2023 | 757k | $4.9M |
| Kynam Capital Management | Dec 2023 | 443k | $3.5M |
| Woodline Partners | Sep 2023 | 210k | $1.4M |
| Susquehanna International | Sep 2023 | 19k | $120k |
| Schonfeld Strategic Advisors | Dec 2023 | 13k | $101k |
| Barclays | Dec 2023 | 6.4k | $51k |